Results 141 to 150 of about 1,773 (164)

PRODH Regulates Tamoxifen Resistance through Ferroptosis in Breast Cancer Cells. [PDF]

open access: yesGenes (Basel)
Zhang P   +8 more
europepmc   +1 more source

Neurological Insights into 16p11.2- And 22q11.2-Related Disorders: A Mini-Review. [PDF]

open access: yesCurr Genomics
Lu YH   +5 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Proline dehydrogenase gene (PRODH) polymorphisms and schizophrenia susceptibility: a meta-analysis

Metabolic Brain Disease, 2017
Previous studies have been conducted to explore the association between proline dehydrogenase gene (PRODH) polymorphisms and schizophrenia (SZ) susceptibility, but providing the controversial results. Here we performed this meta-analysis to determine whether PRODH variants were associated with SZ risk.
Xingzhi Guo, Rui Li, Guo Xingzhi
exaly   +3 more sources

Pharmacoinformatics and molecular docking studies reveal potential novel Proline Dehydrogenase (PRODH) compounds for Schizophrenia inhibition

Medicinal Chemistry Research, 2016
Studies on Schizophrenia, so far reveal a complex picture of neurological malfunctioning reported to be strongly associated with proline dehydrogenase (PRODH). This study employs in silico hybrid approach for virtual screening and molecular docking followed by pharmacophore identification and structural modeling.
Arslan Sehgal, Sehgal Sheikh Arslan
exaly   +2 more sources

Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation

Psychiatric Genetics, 2008
Type I hyperprolinemia (HPI) is an autosomal recessive disorder caused by proline oxidase deficiency. This enzyme is encoded by the proline dehydrogenase (PRODH) gene on 22q11. The functional consequences of different PRODH mutations on proline oxidase activity have been characterized in vitro.
DI ROSA, GABRIELLA   +10 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy